Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 806 results for "international aids vaccine initiative"

A systemic malady: the pervasive problem of misconduct in the biomedical sciences part I: issues and causes. Spring 15
Drug Discovery World

Vanderbilt University Medical Center Joins Human Vaccines Proj...

Vanderbilt University Medical Center (VUMC), the Human Vaccines Project and the International AIDS Vaccine Initiative (IAVI) are pleased to announce that VUMC has become the Project's first Infrosoft, 2 weeks ago
McMaster University

The International AIDS Vaccine Initiative's capacity building activities in East Africa: Evaluating progress and impacts in Kenya, Uganda and Rwanda

Abstract The International AIDS Vaccine Initiative (IAVI) is one of a number of Product Development Partnerships created to bridge the gap between scientific and technological potential and the needs of low income populations in low and middle ...
 Rand2 days ago McMaster prof leads international team in novel HIV research  McMaster University1 week ago Ebola vaccine trial begins in Senegal  EurekAlert!2 weeks ago PED vaccine could aid in disease fight  Manitoba Cooperator3 weeks ago

Indian and East African Experts to Synergize Efforts on HIV Vaccine Research

Despite substantial progress in reducing new incidence of HIV, it remains one of the most challenging viral diseases worldwide, and for India, the country still houses the third highest number of people of people living with the disease at 2.1 ...
 MedIndia4 days ago India, East Africa to synergize efforts on HIV AIDS vaccine research  Can India News5 days ago

Merck Marks 30-Year Milestone in Commitment to Innovation and Care in HIV/AIDS

KENILWORTH, N.J.--( BUSINESS WIRE )--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the company's commitment to HIV and AIDS, which started with a research and development program initiated in ...
 Business Wire1 week ago Merck & Co. Marks 30-Year Milestone In Commitment To Innovation And Care In HIV/AIDS  BioSpace1 week ago Merck & Co. (MRK) Marks 30-Year Milestone In Commitment To Innovation And Care In HIV/AIDS 7/21/2015  ClinicSpace1 week ago Merck : Marks 30-Year Milestone in Commitment to Innovation and Care in HIV/AIDS  4 Traders1 week ago
National Institutes of Health

HIV Vaccine Progress in Animal Studies

HIV, the virus that causes AIDS, attacks and destroys immune cells. For those infected with HIV, antiretroviral therapy helps to prevent the virus from multiplying. But scientists haven't yet been able to design a vaccine that protects people from ...
 National Institutes of Health1 month ago This vaccine could help block HIV  Times of India1 month ago HIV Vaccine That Primes Immune System Almost Ready For Human Trials  Tech Times1 month ago New HIV vaccine candidate primes immune system  The Hindu1 month ago

The 'Bin Laden hunt doctor' case and its impact on polio vaccinations

Initially sentenced to 33 years in prison for being a member of Lashkar-e-Islam, a militant group based in Pakistan's Khyber Agency tribal area, Shakil Afridi is better known for his alleged involvement in a fake hepatitis vaccination campaign in ...
 Deutsche Welle1 month ago

Saving for the World One Dollar At a Time

Philippe Douste Blazy (MD) is founder and chairman of UNITAID, an intergovernmental global health initiative largely funded by solidarity levy on airline tickets around the world, and under-secretary-general, special advisor on innovative financing ...
 AllAfrica.com1 week ago

TSRI awarded two grants to support development of effective vaccine against HIV/AIDS

The Scripps Research Institute (TSRI) has been awarded two grants from the Bill & Melinda Gates Foundation totaling more than $4.5 million to fund efforts to develop a vaccine against HIV/AIDS. "We are delighted by the Gates Foundation's ...
 News-Medical.Net1 week ago TSRI researcher wins $4.5 million in grants to support development of AIDS vaccine  EurekAlert!1 week ago TSRI Researcher Awarded $4.5 Million in Grants to Support Development of AIDS Vaccine  Infection Control Today1 week ago

InnaVirVax presents positive results of IVVAC-3S/P1 study at International AIDS Society Conference

InnaVirVax, a biopharmaceutical company specialized in research and development of therapeutic and diagnostic solutions for major infectious and chronic diseases, today announced the overall results of its Phase I/IIa clinical study (IVVAC-3S/P1) of ...
 News-Medical.Net1 week ago InnaVirVax Presents Highly Encouraging Results Of Its First Clinical Study On VAC-3S Immunotherapy For HIV 7/20/2015  ClinicSpace1 week ago
Holmes Report

Corporate People News In Brief (June 15, 2015)

New people in new roles at Astellas, Modern Markets Initiative, North American International Auto Show, Akron General Health, Blue Hive Environments. NORTHBROOK, IL—Astellas has appointed Tarsis Lopez as associate director, external and digital ...
 Holmes Report1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - international aids vaccine initiative
Get updated on latest news & your favorite topics right in your inbox!
More     Less